|
99 Companies |
|
127 Products |
|
127 Products |
|
70 Mechanisms of Action |
|
7 Trials |
|
2170 News |
|
| 12345678910111213...4344» |
- | Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
Trial termination: Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes (clinicaltrials.gov) - Mar 2, 2024
P2, N=4, Terminated, Sponsor: Haukeland University Hospital
Completed --> Terminated; recruitment difficulties
- | Enrollment change, Glucose variability: Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM (clinicaltrials.gov) - Mar 23, 2023
P=N/A, N=33, Completed, Sponsor: University of Virginia
Completed --> Terminated; recruitment difficulties N=52 --> 33
- ||| Trial completion, HEOR: Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients (clinicaltrials.gov) - May 1, 2019
P=N/A, N=101, Completed, Sponsor: Universit
N=52 --> 33 Active, not recruiting --> Completed
- | Kineret (anakinra) / SOBI
Trial withdrawal: Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes (clinicaltrials.gov) - Apr 20, 2019
P2, N=0, Withdrawn, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed Terminated --> Withdrawn
- | Trial completion: T1REDEEM: Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=301, Completed, Sponsor: University of California, San Francisco
Terminated --> Withdrawn Active, not recruiting --> Completed
- | Trial completion, Trial completion date: Effect of Hypoglycemia on Sleep (clinicaltrials.gov) - Apr 10, 2019
P=N/A, N=10, Completed, Sponsor: Oregon Health and Science University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jan 2017 --> Jul 2018
- | Trial completion: Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment (clinicaltrials.gov) - Apr 5, 2019
P=N/A, N=112, Completed, Sponsor: Samsung Medical Center
Active, not recruiting --> Completed | Trial completion date: Jan 2017 --> Jul 2018 Recruiting --> Completed
- | Biomarker, Trial completion: A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect (clinicaltrials.gov) - Apr 2, 2019
P=N/A, N=29, Completed, Sponsor: Yale University
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose Monitoring (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=12, Completed, Sponsor: Nordsjaellands Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Feb 2019 | Trial primary completion date: Oct 2017 --> Feb 2019
- | Trial completion, Trial completion date, Trial primary completion date: Teleconsultation in Type 1 Diabetes Mellitus (clinicaltrials.gov) - Mar 15, 2019
P=N/A, N=150, Completed, Sponsor: Niguarda Hospital
Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Feb 2019 | Trial primary completion date: Oct 2017 --> Feb 2019 Recruiting --> Completed | Trial completion date: Jul 2017 --> Sep 2018 | Trial primary completion date: Jun 2017 --> Jul 2018
- | Trial completion: Three-dimensional Measurements of Diabetic Foot Ulcers (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=150, Completed, Sponsor: Odense University Hospital
Recruiting --> Completed | Trial completion date: Jul 2017 --> Sep 2018 | Trial primary completion date: Jun 2017 --> Jul 2018 Active, not recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: Pilot Study of Between Visit Interaction to Improve Glycemic Control in Pregnancy With Pre-existing Diabetes (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=12, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: May 2016 --> Jan 2019 | Trial primary completion date: May 2016 --> Jan 2019
- | Trial completion, Trial completion date: Adipose Tissue Function After Pancreas Transplantation (clinicaltrials.gov) - Mar 1, 2019
P=N/A, N=15, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Recruiting --> Completed | Trial completion date: May 2016 --> Jan 2019 | Trial primary completion date: May 2016 --> Jan 2019 Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Feb 2019
- | Byetta (exenatide) / AstraZeneca
Phase classification, Enrollment change: Role of Exenatide in Type 1 Diabetes (clinicaltrials.gov) - Feb 26, 2019
P2, N=11, Completed, Sponsor: Montefiore Medical Center
Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Feb 2019 Phase classification: P4 --> P2 | N=17 --> 11
- | Victoza (liraglutide) / Novo Nordisk
Enrollment change, Trial withdrawal: DIAB-01: Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. (clinicaltrials.gov) - Feb 15, 2019
P1, N=0, Withdrawn, Sponsor: Anna Cruceta
Phase classification: P4 --> P2 | N=17 --> 11 N=20 --> 0 | Not yet recruiting --> Withdrawn
- | Trial completion: Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes (clinicaltrials.gov) - Feb 11, 2019
P2, N=37, Completed, Sponsor: Institut de Recherches Cliniques de Montreal
N=20 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date: Psychosocial Functioning in Young Adults With Type 1 Diabetes (clinicaltrials.gov) - Feb 1, 2019
P=N/A, N=47, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Recruiting --> Completed Active, not recruiting --> Completed | N=120 --> 47 | Trial completion date: Sep 2018 --> Dec 2018
- | Trial completion: Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7) (clinicaltrials.gov) - Feb 1, 2019
P=N/A, N=71, Completed, Sponsor: Centre d
Active, not recruiting --> Completed | N=120 --> 47 | Trial completion date: Sep 2018 --> Dec 2018 Active, not recruiting --> Completed
- | Trial completion, Enrollment change: CADI: Creative Arts Diabetes Initiative for Youth/Young Adults Transitioning to Adult Care (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=12, Completed, Sponsor: University of Manitoba
Active, not recruiting --> Completed Recruiting --> Completed | N=20 --> 12
- | Trial completion: Insulin Management for Exercise in Patients With Type 1 Diabetes (clinicaltrials.gov) - Jan 15, 2019
P=N/A, N=17, Completed, Sponsor: York University
Recruiting --> Completed | N=20 --> 12 Recruiting --> Completed
- | Symlin (pramlintide) / AstraZeneca
Enrollment change: Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes (clinicaltrials.gov) - Jan 8, 2019
P4, N=0, Withdrawn, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Completed N=24 --> 0
- Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study (clinicaltrials.gov) - Dec 21, 2018
P=N/A, N=50, Terminated, Sponsor: Rabin Medical Center
N=24 --> 0 N=220 --> 50 | Trial completion date: Apr 2019 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Apr 2019 --> Dec 2018; The required data was obtained and there was no need to collect further data
- | Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Edu4U: The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes (clinicaltrials.gov) - Dec 17, 2018
P=N/A, N=0, Withdrawn, Sponsor: University of Louisville
N=220 --> 50 | Trial completion date: Apr 2019 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Apr 2019 --> Dec 2018; The required data was obtained and there was no need to collect further data N=178 --> 0 | Trial completion date: Dec 2020 --> Dec 2019 | Not yet recruiting --> Withdrawn | Trial primary completion date: May 2020 --> Dec 2019
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=40, Completed, Sponsor: Rodolfo Alejandro
N=178 --> 0 | Trial completion date: Dec 2020 --> Dec 2019 | Not yet recruiting --> Withdrawn | Trial primary completion date: May 2020 --> Dec 2019 Recruiting --> Completed | N=600 --> 40 | Trial completion date: Dec 2020 --> Nov 2018 | Trial primary completion date: Apr 2020 --> Nov 2018
- ||| Trial completion: Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes (clinicaltrials.gov) - Dec 4, 2018
P=N/A, N=124, Completed, Sponsor: Medtronic Diabetes
Recruiting --> Completed | N=600 --> 40 | Trial completion date: Dec 2020 --> Nov 2018 | Trial primary completion date: Apr 2020 --> Nov 2018 Active, not recruiting --> Completed
- | Trial completion, Trial completion date: Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes (clinicaltrials.gov) - Nov 9, 2018
P4, N=188, Completed, Sponsor: University of Western Ontario, Canada
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Jun 2017
- |||| Trial completion: CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) (clinicaltrials.gov) - Nov 7, 2018
P4, N=456, Completed, Sponsor: Halozyme Therapeutics
Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Jun 2017 Active, not recruiting --> Completed
- | Trial completion, Metastases: Effect of Structured Nutrition Education in Type 1 Diabetes (clinicaltrials.gov) - Nov 5, 2018
P=N/A, N=181, Completed, Sponsor: G
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Humalog pen (insulin lispro) / Eli Lilly
Trial completion: Environmental Effects Type 1 Diabetes Mellitus (clinicaltrials.gov) - Oct 31, 2018
P=N/A, N=10, Completed, Sponsor: University of Hull
Active, not recruiting --> Completed Recruiting --> Completed
- | Phase classification: CTR3: Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use (clinicaltrials.gov) - Oct 29, 2018
P=N/A, N=30, Completed, Sponsor: Jaeb Center for Health Research
Recruiting --> Completed Phase classification: P3 --> P=N/A
- | Trial completion date, Trial primary completion date: Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes (clinicaltrials.gov) - Oct 23, 2018
P2, N=37, Recruiting, Sponsor: Institut de Recherches Cliniques de Montreal
Phase classification: P3 --> P=N/A Trial completion date: Sep 2018 --> Jan 2019 | Trial primary completion date: Sep 2018 --> Jan 2019
- | Trial completion, Trial completion date: DIABECHO: Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over Time (clinicaltrials.gov) - Oct 22, 2018
P=N/A, N=300, Completed, Sponsor: Svendborg Hospital
Trial completion date: Sep 2018 --> Jan 2019 | Trial primary completion date: Sep 2018 --> Jan 2019 Recruiting --> Completed | Trial completion date: Mar 2019 --> Sep 2018
- | tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Trial completion, Trial completion date: Diameter Changes of Retinal Vessels During Hypoxia (clinicaltrials.gov) - Oct 16, 2018
P=N/A, N=58, Completed, Sponsor: University of Aarhus
Recruiting --> Completed | Trial completion date: Mar 2019 --> Sep 2018 Recruiting --> Completed | Trial completion date: Jun 2016 --> Mar 2016
- | metformin / Generic mfg.
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: adAPT: Autoimmune Diabetes Accelerator Prevention Trial (clinicaltrials.gov) - Oct 16, 2018
P4, N=0, Withdrawn, Sponsor: University of Exeter
Recruiting --> Completed | Trial completion date: Jun 2016 --> Mar 2016 N=90 --> 0 | Trial completion date: Jan 2019 --> Dec 2017 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Jan 2018 --> Jun 2017
- | Trial primary completion date: T1REDEEM: Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes (clinicaltrials.gov) - Oct 11, 2018
P=N/A, N=290, Active, not recruiting, Sponsor: University of California, San Francisco
N=90 --> 0 | Trial completion date: Jan 2019 --> Dec 2017 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Jan 2018 --> Jun 2017 Trial primary completion date: Dec 2017 --> Dec 2018
- | Trial completion, Enrollment change: Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication. (clinicaltrials.gov) - Oct 11, 2018
P=N/A, N=100, Completed, Sponsor: University of Athens
Trial primary completion date: Dec 2017 --> Dec 2018 Recruiting --> Completed | N=60 --> 100
- | Trial completion, Trial completion date, Trial primary completion date: Brown Adipose Tissue in Type 1 Diabetes (clinicaltrials.gov) - Oct 11, 2018
P=N/A, N=11, Completed, Sponsor: Per-Ola Carlsson
Recruiting --> Completed | N=60 --> 100 Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Jun 2018 | Trial primary completion date: Sep 2018 --> Jan 2018
- | Trial completion date, Trial initiation date, Trial primary completion date: Edu4U: The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes (clinicaltrials.gov) - Sep 28, 2018
P=N/A, N=178, Not yet recruiting, Sponsor: University of Louisville
Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Jun 2018 | Trial primary completion date: Sep 2018 --> Jan 2018 Trial completion date: May 2020 --> Dec 2020 | Initiation date: Aug 2018 --> Mar 2019 | Trial primary completion date: Nov 2018 --> May 2020
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date, Glucose variability: Glucose Variability in Patients With Type 1 Diabetes With a Sucrose-added Diet (clinicaltrials.gov) - Sep 28, 2018
P=N/A, N=10, Completed, Sponsor: Universidade Federal do Rio de Janeiro
Trial completion date: May 2020 --> Dec 2020 | Initiation date: Aug 2018 --> Mar 2019 | Trial primary completion date: Nov 2018 --> May 2020 Recruiting --> Completed | N=30 --> 10 | Trial completion date: Dec 2019 --> Jan 2018 | Trial primary completion date: Dec 2017 --> Jul 2017
- | Trial completion date: Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes (clinicaltrials.gov) - Sep 25, 2018
P=N/A, N=124, Active, not recruiting, Sponsor: Medtronic Diabetes
Recruiting --> Completed | N=30 --> 10 | Trial completion date: Dec 2019 --> Jan 2018 | Trial primary completion date: Dec 2017 --> Jul 2017 Trial completion date: Jun 2018 --> Oct 2018
- | allopurinol / Generic mfg.
Trial completion: MIKAL: Microalbuminuria and Allopurinol in Type 1 Diabetes (clinicaltrials.gov) - Sep 10, 2018
P4, N=30, Completed, Sponsor: Peter Rossing
Trial completion date: Jun 2018 --> Oct 2018 Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Hypoglycemia in Hospitalized Patients (clinicaltrials.gov) - Sep 7, 2018
P=N/A, N=58, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=100 --> 58 | Trial completion date: Sep 2018 --> Mar 2016 | Trial primary completion date: Sep 2018 --> Dec 2015
- | Trial completion, Trial completion date, Trial primary completion date: CD-DIET: Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial (clinicaltrials.gov) - Sep 5, 2018
P=N/A, N=50, Completed, Sponsor: The Hospital for Sick Children
Active, not recruiting --> Completed | N=100 --> 58 | Trial completion date: Sep 2018 --> Mar 2016 | Trial primary completion date: Sep 2018 --> Dec 2015 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Mar 2018
- | Lantus (insulin glargine) / Sanofi, Lusduna (insulin glargine biosimilar) / Samsung
Enrollment change: A Study of the Safety and Efficacy of MK-1293 Compared to Lantus (clinicaltrials.gov) - Sep 5, 2018
P3, N=508, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Mar 2018 | Trial primary completion date: Jun 2018 --> Mar 2018 N=730 --> 508
- | Enrollment change, Trial withdrawal: CCM: Corneal Confocal Microscopy in Patients With Type 1 Diabetes (clinicaltrials.gov) - Sep 4, 2018
P=N/A, N=0, Withdrawn, Sponsor: Albert Einstein College of Medicine, Inc.
N=730 --> 508 N=100 --> 0 | Not yet recruiting --> Withdrawn
- | Trial completion, Trial completion date: To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves (clinicaltrials.gov) - Aug 27, 2018
P=N/A, N=55, Completed, Sponsor: University of Michigan
N=100 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Aug 2016
- Victoza (liraglutide) / Novo Nordisk
Phase classification: Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting (clinicaltrials.gov) - Aug 21, 2018
P2, N=18, Completed, Sponsor: Albert Einstein College of Medicine, Inc.
Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Aug 2016 Phase classification: P1 --> P2
- | Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Trial completion, Trial completion date: Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes (clinicaltrials.gov) - Aug 21, 2018
P1/2, N=41, Completed, Sponsor: Cambridge University Hospitals NHS Foundation Trust
Phase classification: P1 --> P2 Active, not recruiting --> Completed | Trial completion date: Oct 2016 --> May 2016
- | Phase classification, Enrollment change: Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=10, Completed, Sponsor: Boston Children
Active, not recruiting --> Completed | Trial completion date: Oct 2016 --> May 2016 Phase classification: P1/2 --> P=N/A | N=15 --> 10
- | Trial completion, Trial completion date, Trial primary completion date, HEOR: QUEST: QUality of Control and slEep in Children With diabeteS, Using New Technology (clinicaltrials.gov) - Aug 3, 2018
P=N/A, N=32, Completed, Sponsor: Centre Hospitalier du Luxembourg
Phase classification: P1/2 --> P=N/A | N=15 --> 10 Recruiting --> Completed | Trial completion date: Dec 2017 --> Jul 2018 | Trial primary completion date: Dec 2017 --> May 2018